Metabotropic glutamate receptors for Parkinson's disease therapy. - Wikidata - awgldk - TriplyDB

Metabotropic glutamate receptors for Parkinson's disease therapy.

Metabotropic glutamate receptors for Parkinson's disease therapy.

http://www.wikidata.org/entity/Q41818450

about

Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.Location-dependent signaling of the group 1 metabotropic glutamate receptor mGlu5.α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage.Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias Designing clinical trials for dystonia.Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.Current Nondopaminergic Therapeutic Options for Motor Symptoms of Parkinson's Disease.Functional modulation of G-protein coupled receptors during Parkinson disease-like neurodegeneration.Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease.Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity.Development of PET and SPECT probes for glutamate receptors.Neurotoxic Agent-Induced Injury in Neurodegenerative Disease Model: Focus on Involvement of Glutamate Receptors

P2860

Q26852311-D2210F2B-638C-4A90-A7FF-6CB70AFA06FD Q34112026-8B33F004-FE4E-4A9B-BFEA-8C894ABC1ADA Q34573953-8DFADF67-9E50-49DD-B964-942AFAFC7F07 Q36469995-E2935158-7353-481B-8FB1-EE2496A5ED84 Q36880148-4EF792BD-E597-49A0-848A-11DD75824665 Q37506514-5E23FBA6-4318-4F24-A5B4-E24AFC97823F Q37512670-8562FB9D-4869-4EBA-80F0-03CE7B4603B2 Q38658203-AD1CE4A9-CCDD-4508-A75B-863921D209CC Q42174379-EBD8D529-E770-4793-95F6-835B0BAB16A4 Q42499434-09C0F85C-0B0C-4C86-876E-B4A16DCBA8AC Q47099606-BAE91B49-E62C-45C3-A739-9FE550C31F97 Q53015251-92F02307-A181-445E-BB43-D07E31E1E00B Q58694067-42FE53E0-8A66-4C2E-A1CE-19FC882FB476

P2860

Metabotropic glutamate receptors for Parkinson's disease therapy.

http://www.wikidata.org/entity/Q41818450

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Metabotropic glutamate receptors for Parkinson's disease therapy.

@en

type

label

Metabotropic glutamate receptors for Parkinson's disease therapy.

@en

prefLabel

Metabotropic glutamate receptors for Parkinson's disease therapy.

@en

P1433

Q41818450-1308F7C8-3ABE-40F5-A942-B686F2D0F8BB

P1476

Q41818450-7B4D95F5-28AA-428D-9F73-5C2D7B2BF500

P2093

Q41818450-0DA4BF72-6248-4E90-8475-E8F72A494BE1

Q41818450-6994FD98-CA62-40BF-B0C7-1145F48F16D6

P2860

Q41818450-00221680-37BF-4825-BF13-C46E7C6AC5CB

Q41818450-03155C59-B109-4729-88AF-445E23CCDFC9

Q41818450-04B34033-31A9-4A1A-AE38-70C007890F39

Q41818450-057647C5-3D6A-4E43-B40D-94A430B2928E

Q41818450-09A58D51-C3F6-4711-8A8E-6D2ABE12D39E

Q41818450-10300AE9-9AB0-4C9F-8846-471ACD57496C

Q41818450-11101938-04B9-4718-8FB4-9D7D39301515

Q41818450-11B50D21-45A5-472B-B4A8-9002C8F4D61F

Q41818450-1373DDB8-A898-48A0-A217-D3FBBEE8E414

Q41818450-1396C3DC-9D9F-45A2-AD49-2C915C7A4EBD

P304

Q41818450-7FF2B44D-6CBA-4AEE-9BBD-3014E333A484

P31

Q41818450-38EA53FB-DFB4-47C4-84AD-CDDB0EF53789

P356

Q41818450-721C079B-0999-468B-90A6-F1CE83CD03EF

P478

Q41818450-7E974EA2-F8CB-4F60-B51C-4DC294B09CFD

P50

Q41818450-D9FCEA69-A438-4944-8026-ACCC7353E5E2

P577

Q41818450-D88BC09E-B14E-41AE-AEC5-D9843E86BA3F

P5875

Q41818450-D36C0397-AFCE-49AD-A79D-B9727BA60EB8

P698

Q41818450-71FAF9CF-C002-4324-BD96-0C15EB2C361C

P921

Q41818450-957D6704-1B1D-4525-AAF5-6733425421A3

P932

Q41818450-0F5500F9-72FD-4386-BAFA-F885738CA8DD

P356

P1433

Parkinson's disease

P1476

Metabotropic glutamate receptors for Parkinson's disease therapy.

@en

P2093

Baltazar Gomez-Mancilla

http://www.w3.org/2001/XMLSchema#string

Fabrizio Gasparini

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4.

Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment

Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP

The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat

Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trial

Metabotropic glutamate receptors in the basal ganglia motor circuit

Glutamate receptor ion channels: structure, regulation, and function

Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys

AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys

SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5

P304

196028

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/196028

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Thérèse Di Paolo

P577

2013-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

249322386

http://www.w3.org/2001/XMLSchema#string

P698

23853735

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3703788

http://www.w3.org/2001/XMLSchema#string